In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Wednesday, 5:11 AM

April 8, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Ceasefire

The US and Iran agreed to a two-week ceasefire requiring Iran to immediately reopen the Strait of Hormuz, which handles 20% of global oil shipments.

The US halted offensive actions; oil prices fell, with Brent crude dropping 16% to $91.70 a barrel. Iran agreed to stop attacks if safe passage is ensured and may charge passage fees to fund reconstruction.

Israel paused strikes on Iran but continues attacks in Lebanon. Gulf nations reported missile strikes despite the truce. The six-week war has killed over 5,000 people.

Pakistan will mediate talks to start April 10. Trust remains fragile, and key issues like Iran’s nuclear program remain unresolved.

Sources: AP News, Reuters, Bloomberg, WallStreetJournal

Militia Hostage Release

US freelance journalist Shelly Kittleson, kidnapped in Baghdad on March 31 by Kataib Hezbollah, was released April 7.

The Iran-backed militia demanded she leave Iraq immediately. Kittleson was abducted in a two-car operation; one kidnapper was arrested after a police chase near Babil province.

Iraqi government and security forces negotiated her release despite communication difficulties with militia leaders underground. US officials had warned Kittleson of threats; the State Department and FBI aided her release.

Kittleson, who reports from conflict zones, resisted leaving despite being on a militia hit list targeting female journalists. This follows the 2023 kidnapping and 2025 release of Elizabeth Tsurkov by the same militia.

Sources: Reuters, BBC, EuroNews

Claude Mythos

Anthropic released Claude Mythos Preview, an AI model that autonomously identifies and exploits software vulnerabilities, outperforming nearly all human experts.

Mythos detected thousands of zero-day flaws, including a 27-year-old OpenBSD remote-crash bug, a 16-year-old FFmpeg flaw, and Linux kernel exploits enabling system takeover.

It achieves an 83.1% success rate in reproducing and exploiting vulnerabilities, up from 66.6% in the prior model. Twelve partners, including Amazon, Apple, Google, and Microsoft, formed Project Glasswing to deploy Mythos for defensive security, backed by $100 million in model credits and $4 million donated to open-source groups.

The initiative aims to reduce patching windows from months to minutes, with public reports due in 90 days. Mythos won’t be publicly released due to risks.

Sources: Anthropic, Gizmodo, Incrypted, 36kr, AXIOS

Ford Tariff Relief

Novelis’s Oswego aluminum mill, key for automotive sheet supply, remains closed until June 2026 after two fires. The company shifted production to Europe and South Korea, but imports face a 50% U.S. tariff, driving costs up.

Ford, a major customer, posted a $2 billion loss due to the shutdown and expects $1 billion more in imported aluminum expenses this year.

The administration declined Ford’s request for temporary tariff relief, though it altered metal tariffs, reducing many to 25%.

Aluminum prices and delivery premiums have increased, adding costs. The shutdown intensified supply bottlenecks, straining U.S. automakers amid tariffs and trade disruptions.

Sources: WallStreetJournal, Agenzianova

Chronic Pain Circuit

Stanford researchers identified a brain circuit driving chronic pain, distinct from immediate pain pathways, affecting 60 million Americans.

This circuit starts in the spinal cord, passes through the thalamus, cortex, and brainstem, then loops back. Blocking it in mice eliminated chronic pain without impairing normal pain detection; activating it induced lasting sensitivity.

It activates only after injury or inflammation and operates alongside a pain-reducing circuit. Scientists aim to understand its molecular basis to develop drugs targeting chronic pain without affecting normal pain.

They are investigating if humans have a similar circuit. This discovery offers a new target for treatments that could reduce reliance on opioids.

Sources: SciTechDaily

Tuberculosis Nasal Vaccine

Johns Hopkins researchers developed a nasal DNA vaccine combining relMtb and Mip3α genes targeting drug-tolerant tuberculosis (TB).

It boosts lung immune responses, enhancing clearance and reducing relapse. In mice, it improved immune activity and the efficacy of TB drugs bedaquiline, pretomanid, and linezolid.

In rhesus macaques, it induced strong TB-specific immune responses lasting six months but wasn’t tested for infection protection. The vaccine attracts dendritic cells to present TB proteins to T cells, with nasal delivery targeting lung immunity.

Its DNA design ensures stability and efficient production. Further studies are needed before human trials. This vaccine could shorten treatment and combat drug-resistant TB.

Sources: SciTechDaily

“You want to make sure you don't catch the Fools' Disease and let it put you in an early grave. It is a general rule of nature that a truly wise person hangs on until his brain wears out and he loses his reason, whereas a blown-in-the-glass fool drops dead long before he ever gets around to finding his.”

Baked with love,

Anna Eisenberg ❤️